Robotic Prostatectomy and Prostate Cancer-Related Medicaid Spending: Evidence from New York State.

Journal: Journal of general internal medicine
PMID:

Abstract

BACKGROUND: Robotic prostatectomy is a costly new technology, but the costs may be offset by changes in treatment patterns. The net effect of this technology on Medicaid spending has not been assessed.

Authors

  • Hansoo Ko
    New York University Robert F. Wagner Graduate School of Public Service, New York, NY, USA. hansooko@nyu.edu.
  • Sherry A Glied
    New York University Robert F. Wagner Graduate School of Public Service, New York, NY, USA.